FindTrial
Sign In

Effects of intravenous lidocaine and thoracic nerve block on quality of recovery and chronic pain in breast cancer surgery

Effects of intravenous lidocaine and thoracic nerve block on quality of recovery and chronic pain in breast cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098280
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Intravenous infusion of lidocaine group:Intravenous lidocaine
Thoracic nerve block group:Ultrasound guided thoracic nerve block anesthesia

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years,2.American Society of Anaesthesiologists (ASA) physical status I or ?,3. Diagnosed with breast cancer.

Exclusion criteria

Exclusion criteria: 1.Coagulation abnormalities,2. Severe heart, liver, kidney and lung diseases, neurological and psychiatric disease,3.Puncture site infection,4.Amino-amide local anesthetic allergy, 5.Refusal to participate;

Design outcomes

Primary

MeasureTime frame
Score of QoR-40;Chronic postsurgical pain,CPSP;—

Secondary

MeasureTime frame
NRS pain scores were evaluated at 2, 4, 8, 12, 24 and 48h after surgery;The cumulative consumption of remifentanil during surgery;The cumulative consumption of sufentanil for postoperative analgesia;Number of rescue analgesia and cumulative consumption of rescue remedy;Ramsay sedation score after surgery;—

Countries

China

Contacts

Public ContactShenghong Hu

Anqing Municipal Hospital

hushenghong-1@163.com+86 556 5223930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026